DOVER, Del. — The CEO of Chemours is assuring investors that the chemical company is financially sound, despite a disappointing second quarter and a high-stakes lawsuit against former parent company DuPont. Chemours lowered its full-year guidance Thursday as it reported net income of $96 million, or 57 cents per share, in the second quarter. That’s
